Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 4Tongue Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Lung Neoplasms 1

Interventions

Fluorodeoxyglucose F18 2talactoferrin alfa 1fluoromisonidazole 1Zinc Oxide 1Tobacco Use Cessation Devices 1Rubidium-82 1Ritonavir 1Radiotherapy 1Quality of Life 1Patient Reported Outcome Measures 1Nicotine 1Molecular Diagnostic Techniques 1Magnetic Resonance Spectroscopy 1Indinavir 1Immunotherapy 1Immunohistochemistry 1Gefitinib 1FPP(RGD)2 1Erlotinib Hydrochloride 1Drug Therapy 1Cyclophosphamide 1Cryosurgery 1Cetuximab 1Biopsy 1Biological Therapy 15-fluoropentyl-2-methylmalonic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Tongue Neoplasms × talactoferrin alfa × Thoracic × Clear all
NCT01528137 2016-08-02

Talactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck Cancer

Stanford University

Phase 1 Terminated
4 enrolled
Head & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Salivary Gland Neoplasms, Tongue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡